期刊文献+

食药两用菌及植物对实验性糖尿病小鼠血糖的影响 被引量:1

EFFECTS OF 3 EDIBLE AND MEDICINAL FUNGI AND 2 PLANTS ON BLOOD GLUCOSE IN EXPERIMENTAL DIABETES MICE
下载PDF
导出
摘要 目的研究虫草菌丝粉(Cordyceps sinensis)、蛹虫草粉(Cordyceps militaris)、灵芝超细粉(Ganoderma lucidum)等3种食药两用菌和苦瓜粉(Momordica charantia)、桑叶粉(Folium mori)2种植物样品对正常及糖尿病小鼠血糖调节的影响.方法筛选空腹血糖在3~5 mmol·L-1之间的小鼠作为正常动物模型,随机分组,每组10只.高血糖动物模型组:禁食24 h后给予尾静脉注射四氧嘧啶75 mg·kg-1.72 h后,尾静脉取血测血糖值,并选用血糖值10 mmol·L-1以上者再按血糖水平随机分成1个对照组(以同体积注射用水灌胃)和5个样品组.所有样品组均分别以上述3个食药两用菌和2个植物样品,每天灌胃1次,连续灌胃给药28 d后,进行空腹血糖和糖耐量测定.结果 3种食药两用菌和2种植物与正常对照组相比差异均无显著性.而虫草菌丝粉样品组动物0 h、0.5 h和2 h时相的血糖分别较高血糖对照组降低52.4%、41.3%、55.8%(P<0.01);蛹虫草粉样品组动物0 h、0.5 h和2 h时相的血糖也分别较高血糖对照组降低30.5%、26.6%和52.2%(P<0.05,P<0.01);灵芝超细粉样品组动物则显示在0.5 h和2 h时相的血糖较高血糖对照组分别降低20.3%和39.9%(P<0.05,P<0.01);此外,苦瓜粉样品组动物仅表现在2 h时相的血糖较高血糖对照组降低23.0%(P<0.05),其他差异均无显著性.结论 虫草菌丝粉、蛹虫草粉、灵芝超细粉和苦瓜粉能显著抵抗或减缓吸收外源性葡萄糖的作用,其中虫草菌丝粉和蛹虫草粉能显著降低四氧嘧啶糖尿病小鼠的空腹血糖,但对糖尿病小鼠的糖耐量未见有明显的改善作用. Objective To investigate the effects of three kinds of edible and medicinal fungi ( Cordyceps sinensis, Cordyceps militaris, Ganoderma luc/dum) and two kinds of plants (Momordica charantia and Folium mori) on blood glucose level in normal and experimental diabetes mice. Methods Sixty mice were randomly divided into 6 normal model groups ( 1 normal control and 5 treated groups), another 60 mice were injected with 75 mg· kg^-1 alloxan to induce diabetes. These diabetic mice were also divided into 6 groups ( 1 control and 5 treated groups). The above components were given intragastricaUy to the treated groups for 28d and then caudal venous blood glucose were determined. Results These edible and medicinal fungi, and plants had no obvious effects on blood glucose level in normal mice, but among the diabetic mice, the levels of blood glucose were obviously decreased in treated mice. The levels of blood glucose (postprandial 0 h, 0.5 h, and 2.0 h), were 52.4% ,41.3% ,55.8% less respectively (P 〈 0.01) in Cordyceps sinensis diabetic group, and 30.5% ,26.6% ,52.2% less respectively (P 〈 0.05, P,0.01) in Cordyceps militaris diabetic group than in diabetic control group. The levels of blood glucose (postprandial 0.5 h, 2.0 h) in Ganoderma lucidum diabetic group, and that(postprandial 2.0 h) in Momordica charantia diabetic group were 20.3 %, 39.9 %, and 23.0% less respectively ( P 〈 0.05, P 〈 0.01 ) than in diabetic control group. Conclusion Cordyceps sinensis, and Cordyceps militaris could obviously decrease the fasting blood glucose level in diabetic mice. In addition, Cordyceps sinensis, C.anoderma lucidum, Cordyceps militaris, and Momordica charantia might also resist the increase in blood glucose induced by exogenous glucose, but no obvious effect on the blood glucose tolemce.
出处 《解放军预防医学杂志》 CAS 北大核心 2005年第5期327-330,共4页 Journal of Preventive Medicine of Chinese People's Liberation Army
基金 上海市科委重点攻关课题项目(No.013912048)
关键词 食药两用菌 植物 糖尿病 血糖 四氧嘧啶 edible and medicinal fungi plant diabetes blood glucose alloxan
  • 相关文献

参考文献10

二级参考文献31

共引文献121

同被引文献11

  • 1DOBERS J, KORDMANN M. Expression, purification human dipeptidyl peptidase cells [J]. Protein Expres 527-532. MC, LEDDERMANN and characterization of IV/CD26 in Sf9 insect Purif, 2002, 25 (3):527-532.
  • 2MENTLEIN R. Dipeptidyl-peptidaselV ( CD26 ) role in the inactivation of regulatory peptides[J]. Regul Pept, 1999, 85(1) :9-24.
  • 3ARULMOZHI DK, PORTHA B. GLP-1 based therapy for type 2 diabetes[J]. Eur J Pharm Sci, 2006, 28(1-2) :96-108.
  • 4XU G, STOFFERS DA, HABENER JF, et al. Exendin-4 stimulates both -cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats [J]. Diabetes, 1999, 48(12) :2270-2276.
  • 5ZHOU J, WANG X, PINEYRO MA, et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon-and insulin- producing cells [J]. Diabetes, 1999, 48 (12): 2358-2366.
  • 6HOLST JJ, DEACON CF. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus[J]. Curr Opin Pharmacol, 2004, 4 (6) : 589-596.
  • 7RUSSELL-JONES D, GOUGH S. Recent advances in incretin-based therapies [J]. Clin Endocrinol (Oxf), 2012, 77(4) :489-499.
  • 8DAVIS HR, MULLINS DE, PINES JM, et al. Effect of chronic central administration of glucagon-like peptide-1 amide ( 7-36 ) on food consumption and body weight in normal and obese rats[J]. Obes Res, 1998, 6(2) :147-156.
  • 9MEIER JJ, GALLWITZ B, SCHMIDT WE, et al. Glucagon-like peptide 1 as a regulator of food intake and body weight., therapeutic perspectives[J]. Eur J Pharmacol, 2002, 440 (2-3):269-279.
  • 10MASASHI T. Glycan structures of ganoderans b and c, hypoglycemic glycans of Ganoderma lucidum fruit bodies[J]. Phytochemistry, 1986, 25 (12) :2817-2820.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部